Reactive oxygen species in cancer: Mechanistic insights and therapeutic innovations

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Reactive oxygen species (ROS) are increasingly recognized for their complex roles in cancer.
• While essential for signaling in healthy cells, ROS are dysregulated in cancer, promoting proliferation and survival.
• Cancer cells exploit ROS for growth but also develop antioxidant defenses, creating a complex dependency.

Purpose of the Study:

• To explore the dual roles of reactive oxygen species (ROS) in cancer progression and vulnerability.
• To investigate how ROS influence key cancer signaling pathways and the tumor microenvironment.
• To identify opportunities for therapeutic intervention by targeting ROS balance.

Main Methods:

• Literature review and analysis of existing research on ROS in cancer.
• Examination of ROS involvement in cancer-related signaling pathways (MAPK, PI3K/Akt, JNK, NF-κB).
• Analysis of ROS impact on matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) in the tumor microenvironment (TME).

Main Results:

• ROS are critical for cancer progression, activating pathways like MAPK, PI3K/Akt, and JNK, and inducing inflammation via NF-κB.
• ROS facilitate cancer spread by promoting MMPs and VEGF, which degrade tissue barriers and foster the tumor microenvironment.
• The effect of ROS (promoting growth vs. cell death) depends on timing, location, quantity, and cellular context.

Conclusions:

• The intricate balance of ROS in cancer presents a significant therapeutic vulnerability.
• Targeting ROS dynamics could offer novel treatment strategies by converting cancer's reliance on ROS into a weakness.
• Further research into ROS modulation holds promise for innovative cancer therapies.